CXM
Price
$6.63Alerts
Change
+$0.12 (+1.84%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
1.55B
20 days until earnings call
Intraday BUY SELL Signals
OPRX
Price
$8.95Alerts
Change
-$0.40 (-4.28%)
Updated
Nov 11 closing price
Capitalization
165M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CXM vs OPRX

CXM vs OPRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CXM vs. OPRX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CXM is a Hold and OPRX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CXM with price predictions
Nov 11, 2026

CXM in upward trend: 10-day moving average broke above 50-day moving average on October 26, 2026

The 10-day moving average for CXM crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

CXM moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +10.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where CXM advanced for three days, in 198 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 139 of 199 cases where CXM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Bearish Trend Analysis

The 10-day RSI Indicator for CXM moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 26 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CXM as a result. In 67 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for CXM turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 34 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CXM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

CXM broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CXM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.981) is normal, around the industry mean (-1.906). P/E Ratio (66.700) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.697) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.575) is also within normal values, averaging (70.383).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CXM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for OPRX with price predictions
Nov 11, 2026

OPRX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for OPRX moved above the 200-day moving average on October 07, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +9.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPRX advanced for three days, in 196 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 106 of 125 cases where OPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

Bearish Trend Analysis

The 10-day RSI Indicator for OPRX moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 18 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 60 cases where OPRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OPRX as a result. In 76 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for OPRX turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 37 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

OPRX broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. OPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.259) is normal, around the industry mean (4.477). P/E Ratio (33.692) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.463) is also within normal values, averaging (6.065).

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

FUNDAMENTALS RATINGS
OPRX: Fundamental Ratings
OPRX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CXMOPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 23 days ago
68%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CXM: $6.64 vs. OPRX: $8.95)
Brand notoriety: CXM and OPRX are both not notable
CXM represents the Packaged Software, while OPRX is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: CXM: 49% vs. OPRX: 278%
Market capitalization -- CXM: $1.55B vs. OPRX: $165M
CXM [@Packaged Software] is valued at $1.55B. OPRX’s [@Services to the Health Industry] market capitalization is $165M. The market cap for tickers in the [@Packaged Software] industry ranges from $39 to $269.45B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Packaged Software] industry is $10.32B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CXM’s FA Score shows that 1 FA rating(s) are green while OPRX’s FA Score has 0 green FA rating(s).

  • CXM’s FA Score: 1 green, 4 red.
  • OPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CXM is a better buy in the long-term than OPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CXM’s TA Score shows that 5 TA indicator(s) are bullish while OPRX’s TA Score has 3 bullish TA indicator(s).

  • CXM’s TA Score: 5 bullish, 5 bearish.
  • OPRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CXM is a better buy in the short-term than OPRX.

Price Growth

CXM (@Packaged Software) experienced а -2.92% price change this week, while OPRX (@Services to the Health Industry) price change was -8.86% for the same time period.

The average weekly price growth across all stocks in the @Packaged Software industry was -2.38%. For the same industry, the average monthly price growth was -3.83%, and the average quarterly price growth was +4.03%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.38%. For the same industry, the average monthly price growth was +2.22%, and the average quarterly price growth was +27.51%.

Reported Earning Dates

CXM is expected to report earnings on Dec 02, 2026.

OPRX is expected to report earnings on Feb 25, 2027.

Industries' Descriptions

@Packaged Software (-2.38% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

@Services to the Health Industry (+0.38% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

CXM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CXM has been closely correlated with FRSH. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CXM jumps, then FRSH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CXM
1D Price
Change %
CXM100%
+1.84%
FRSH - CXM
70%
Closely correlated
+1.68%
ASAN - CXM
68%
Closely correlated
+2.29%
DOCU - CXM
66%
Loosely correlated
+3.21%
BL - CXM
66%
Loosely correlated
+0.33%
ADSK - CXM
65%
Loosely correlated
-0.04%
More

OPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPRX has been loosely correlated with DOCS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPRX jumps, then DOCS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPRX
1D Price
Change %
OPRX100%
-4.28%
DOCS - OPRX
42%
Loosely correlated
+2.47%
CERT - OPRX
41%
Loosely correlated
-3.26%
CXM - OPRX
38%
Loosely correlated
+1.84%
COIN - OPRX
37%
Loosely correlated
+3.13%
RIOT - OPRX
36%
Loosely correlated
+1.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVSC72.060.41
+0.57%
Avantis U.S Small Cap Equity ETF (AVSC)
DBE35.110.12
+0.34%
Invesco DB Energy Fund (DBE)
EFAX53.920.14
+0.26%
State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF (EFAX)
AALG18.02N/A
N/A
Leverage Shares 2X Long Aal Daily ETF
FBDC17.01-0.06
-0.35%
FT Confluence BDC & Specialty Finance Income ETF (FBDC)